These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1008726)

  • 41. [Long-term administration of verapamil in coronary disease].
    Tkaczewski W; Goch JH; Bala T; Kuklewicz C
    Pol Tyg Lek; 1977 Oct; 32(44):1719-21. PubMed ID: 917918
    [No Abstract]   [Full Text] [Related]  

  • 42. [Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
    Carrasco RM; da Rocha MM; Luna RL
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():24-32. PubMed ID: 7325860
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of verapamil in patients with asymptomatic stress-induced ischemia.
    Zilberman A; Rogel S
    Arch Intern Med; 1989 May; 149(5):1062-4. PubMed ID: 2719499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in left ventricular regional wall motion induced by Verapamil (author's transl)].
    Barbieri E; Allegri P; Morlino T; Vincenzi M
    G Ital Cardiol; 1980; 10(2):155-60. PubMed ID: 6768633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of ergometric studies in practice and their evaluation].
    Schmidt FL
    Dtsch Med J; 1967 Oct; 18(20):623-8. PubMed ID: 5610710
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
    Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
    Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
    [No Abstract]   [Full Text] [Related]  

  • 48. [The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort].
    Novo S; Davì G; Riolo F; Pinto A; Avellone G; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(2):139-48. PubMed ID: 7236439
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of Intencordin treatment of patients with coronary artery disease].
    Adamska-Dyniewska H; Goch JH; Gajewska B
    Wiad Lek; 1973 Oct; 26(20):1937-40. PubMed ID: 4587344
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 53. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
    Paperno AA; Kovalev GV; Gurbanov KG
    Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of potassium orotate on the contractile function of the myocardium in patients with coronary aterosclerosis].
    Gorbachev VV; Vecherskiĭ GA; Baranov LG
    Klin Med (Mosk); 1975 Jan; 53(1):86-90. PubMed ID: 1134027
    [No Abstract]   [Full Text] [Related]  

  • 55. Exercise induced ventricular arrhythmias and effects of suppressive therapy with propranolol and verapamil.
    Tewari SC; Das BK; Parashar SK; Prabhakaran SN; Grover DN; Rastogi DS
    Indian Heart J; 1982; 34(3):162-5. PubMed ID: 7129494
    [No Abstract]   [Full Text] [Related]  

  • 56. [A comparative evaluation of the anti-ischemic action of verapamil in different models of myocardial ischemia].
    Gurbanov KK; Kovalev GV; Paperno AA
    Farmakol Toksikol; 1991; 54(4):21-3. PubMed ID: 1786814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reaction of the cardiorespiratory system to physical load in ischemic heart disease under the influence of comprehensive treatment with physical factors].
    Danilov VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1973; 38(1):28-32. PubMed ID: 4775664
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of isosorbide dinitrate of prolonged action on the prevention of myocardial ischemia induced by exercise: correlation with nitrate blood levels].
    Duprat R; Meneghelo RS; Batlouni M; Hoxter G
    Arq Bras Cardiol; 1975 Jun; 28(3):369-77. PubMed ID: 1180718
    [No Abstract]   [Full Text] [Related]  

  • 60. [Action of verapamil on the dynamics of heart conduction].
    Amino JG; Studart PC; de Brito AH; Brando PR; Maia IG; Almeida G; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():37-41. PubMed ID: 889473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.